Prostatype Genomics AB (publ) at its annual general meeting held on June 2, 2022, Mattias Prage was elected as new member of the board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.049 SEK | -12.81% | +11.36% | -48.42% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-48.42% | 5.21M | |
-22.04% | 8.54B | |
+68.77% | 4.32B | |
-0.82% | 2.53B | |
-39.22% | 2.48B | |
-9.09% | 1.9B | |
-18.18% | 1.59B | |
-40.70% | 1.23B | |
+13.38% | 1.13B | |
+16.15% | 994M |
- Stock Market
- Equities
- PROGEN Stock
- News Prostatype Genomics AB
- Prostatype Genomics AB Appoints Mattias Prage as Member of the Board